Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AVEO Pharmaceuticals Inc. AVEO

Healthcare Biotechnology
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States.


NDAQ:AVEO - Post by User

AVEO Pharmaceuticals Inc. > Holding strong and upward pressure
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by ARNULFon Jul 13, 2018 12:13am
20 Views
Post# 28310451

RE:RE:RE:RE:RE:Holding strong and upward pressure

RE:RE:RE:RE:RE:Holding strong and upward pressure LOL And an inverse head and shoulders on the one day chart.  AVEO did not publish that they were approved in Scotland on Monday. Speculation by other boards is AVEO already bought out.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities